WILMINGTON, N.C.--(BUSINESS WIRE)--Jaguar Holding Company II (the “Company”) and Pharmaceutical Product Development, LLC (“PPD” and, together with the Company, the “Issuers”) today announced that they intend to commence an offering of $1,125 million in aggregate principal amount of senior notes due 2023 (the “Notes”) in a private offering that is exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”).
Help employers find you! Check out all the jobs and post your resume.
